WO2003103614A3 - Compositions for the treatment of edematous-firbrosclerotic panniculopathy - Google Patents

Compositions for the treatment of edematous-firbrosclerotic panniculopathy Download PDF

Info

Publication number
WO2003103614A3
WO2003103614A3 PCT/IB2003/002216 IB0302216W WO03103614A3 WO 2003103614 A3 WO2003103614 A3 WO 2003103614A3 IB 0302216 W IB0302216 W IB 0302216W WO 03103614 A3 WO03103614 A3 WO 03103614A3
Authority
WO
WIPO (PCT)
Prior art keywords
panniculopathy
treatment
cellulite
compositions
angiogenic
Prior art date
Application number
PCT/IB2003/002216
Other languages
French (fr)
Other versions
WO2003103614A2 (en
Inventor
Carlo Ghisalberti
Original Assignee
Carlo Ghisalberti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlo Ghisalberti filed Critical Carlo Ghisalberti
Priority to AU2003240174A priority Critical patent/AU2003240174A1/en
Publication of WO2003103614A2 publication Critical patent/WO2003103614A2/en
Publication of WO2003103614A3 publication Critical patent/WO2003103614A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to the use of angiogenic agents for the manufacture compositions for the treatment of cellulite, better defined by the term "edematousfibrosclerotic panniculopathy" to elicit the endothelial repair and/or the neovascularization of the cellulite-affected area and tissues. The invention also claims a method for treating cellulite which comprises the administration of an angiogenic agent, preferably selected from angiogenic phospholipids, hyaluronan oligosaccharides, peptide growth factors and combination thereof and, optionally, secondary angiogenic agents.
PCT/IB2003/002216 2002-06-11 2003-06-10 Method and compositions for the treatment of edematous-firbrsclerotic panniculopathy WO2003103614A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003240174A AU2003240174A1 (en) 2002-06-11 2003-06-10 Compositions for the treatment of edematous-firbrosclerotic panniculopathy

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2002A001280 2002-06-11
IT2002MI001280A ITMI20021280A1 (en) 2002-06-11 2002-06-11 ANTI-CELLULITE TREATMENT METHOD

Publications (2)

Publication Number Publication Date
WO2003103614A2 WO2003103614A2 (en) 2003-12-18
WO2003103614A3 true WO2003103614A3 (en) 2004-10-21

Family

ID=29727270

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2003/002216 WO2003103614A2 (en) 2002-06-11 2003-06-10 Method and compositions for the treatment of edematous-firbrsclerotic panniculopathy

Country Status (3)

Country Link
AU (1) AU2003240174A1 (en)
IT (1) ITMI20021280A1 (en)
WO (1) WO2003103614A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100392400C (en) * 2005-11-01 2008-06-04 上海中医药大学 Pretreatment method of samples for determination of salvianolic acid B concentration in biological fluid
ITMI20060981A1 (en) * 2006-05-18 2007-11-19 Vitrupharma S R L MEDICATED PATCHES TO TREAT CELLULITIS AND LOCALIZED ADIPOSITY
US8742167B2 (en) * 2008-01-11 2014-06-03 Shanghai Institute Of Pharmaceutical Industry Therapeutic formulations based on asiatic acid and selected salts thereof
CN105708778B (en) * 2016-02-02 2018-09-21 广州赛莱拉干细胞科技股份有限公司 A kind of skin care compositions and a kind of face cream and preparation method thereof

Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987001939A1 (en) * 1985-10-01 1987-04-09 Angio-Medical Corporation Compositions containing lipid molecules with enhanced angiogenic activity
EP0659755A1 (en) * 1993-12-27 1995-06-28 Roussel Uclaf Phospholipids as vectors for active molecules, their preparation and their use in cosmetic or dermatologic compositions
WO1997009989A1 (en) * 1995-09-14 1997-03-20 Lxr Biotechnology Inc. Compositions with anti-apoptotic activity, containing a mixture of phospholipids
WO1998000101A1 (en) * 1996-06-27 1998-01-08 Indústria e Comércio de Cosméticos Natura Ltda. Cosmetic compositions for skin care, specially as cellulite preventing or reducing agent
WO1999026632A1 (en) * 1997-11-20 1999-06-03 Statens Serum Institut Phospholipids having antimicrobial activity with or without the presence of antimicrobials
JP2000109409A (en) * 1998-10-05 2000-04-18 Kao Corp Acne prevention / improvement agent
FR2785805A1 (en) * 1998-11-18 2000-05-19 Lavipharm Lab Compositions rich in lipids obtained from vegetable sources by solvent extraction, suitable for use in cosmetics, pharmaceuticals, and foodstuffs
WO2000045774A1 (en) * 1999-02-04 2000-08-10 Phares Pharmaceutical Research Nv Membrane lipid compositions
WO2001012141A1 (en) * 1999-08-18 2001-02-22 Kyowa Hakko Kogyo Co., Ltd. Hair growth stimulants
WO2001017498A1 (en) * 1999-09-09 2001-03-15 Pentapharm Ltd. Use of conjugated linoleic acid (cla) for the topical treatment of cellulite
WO2001026617A1 (en) * 1999-10-08 2001-04-19 Coty B.V. Cosmetic preparation of active substances with a synergistically increased radical protection factor
JP2002293711A (en) * 2001-03-23 2002-10-09 General Topics Srl Active ingredients based on lipoic acid and polyenol fatty acids
WO2002098436A1 (en) * 2001-06-05 2002-12-12 Indena S.P.A. Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite
WO2003011873A2 (en) * 2001-07-27 2003-02-13 Neptune Technologies & Bioressources Inc. Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications
WO2003068210A1 (en) * 2002-02-12 2003-08-21 Hunza Di Pistolesi Elvira & C. S.A.S. N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
WO2003103625A2 (en) * 2002-06-11 2003-12-18 Carlo Ghisalberti Dermocosmetic treatment by metabolic phospholipids

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987001939A1 (en) * 1985-10-01 1987-04-09 Angio-Medical Corporation Compositions containing lipid molecules with enhanced angiogenic activity
EP0659755A1 (en) * 1993-12-27 1995-06-28 Roussel Uclaf Phospholipids as vectors for active molecules, their preparation and their use in cosmetic or dermatologic compositions
WO1997009989A1 (en) * 1995-09-14 1997-03-20 Lxr Biotechnology Inc. Compositions with anti-apoptotic activity, containing a mixture of phospholipids
WO1998000101A1 (en) * 1996-06-27 1998-01-08 Indústria e Comércio de Cosméticos Natura Ltda. Cosmetic compositions for skin care, specially as cellulite preventing or reducing agent
WO1999026632A1 (en) * 1997-11-20 1999-06-03 Statens Serum Institut Phospholipids having antimicrobial activity with or without the presence of antimicrobials
JP2000109409A (en) * 1998-10-05 2000-04-18 Kao Corp Acne prevention / improvement agent
FR2785805A1 (en) * 1998-11-18 2000-05-19 Lavipharm Lab Compositions rich in lipids obtained from vegetable sources by solvent extraction, suitable for use in cosmetics, pharmaceuticals, and foodstuffs
WO2000045774A1 (en) * 1999-02-04 2000-08-10 Phares Pharmaceutical Research Nv Membrane lipid compositions
WO2001012141A1 (en) * 1999-08-18 2001-02-22 Kyowa Hakko Kogyo Co., Ltd. Hair growth stimulants
EP1214928A1 (en) * 1999-08-18 2002-06-19 Kyowa Hakko Kogyo Co., Ltd. Hair growth stimulants
WO2001017498A1 (en) * 1999-09-09 2001-03-15 Pentapharm Ltd. Use of conjugated linoleic acid (cla) for the topical treatment of cellulite
WO2001026617A1 (en) * 1999-10-08 2001-04-19 Coty B.V. Cosmetic preparation of active substances with a synergistically increased radical protection factor
JP2002293711A (en) * 2001-03-23 2002-10-09 General Topics Srl Active ingredients based on lipoic acid and polyenol fatty acids
WO2002098436A1 (en) * 2001-06-05 2002-12-12 Indena S.P.A. Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite
WO2003011873A2 (en) * 2001-07-27 2003-02-13 Neptune Technologies & Bioressources Inc. Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications
WO2003068210A1 (en) * 2002-02-12 2003-08-21 Hunza Di Pistolesi Elvira & C. S.A.S. N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
WO2003103625A2 (en) * 2002-06-11 2003-12-18 Carlo Ghisalberti Dermocosmetic treatment by metabolic phospholipids

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE CAPLUS [online] XP002267809, retrieved from STN Database accession no. 2000:252033 *
DATABASE WPI Derwent World Patents Index; AN 2003-270789 *
PATENT ABSTRACTS OF JAPAN vol. 2003, no. 02 5 February 2003 (2003-02-05) *

Also Published As

Publication number Publication date
WO2003103614A2 (en) 2003-12-18
AU2003240174A1 (en) 2003-12-22
AU2003240174A8 (en) 2003-12-22
ITMI20021280A1 (en) 2003-12-11

Similar Documents

Publication Publication Date Title
GB0108592D0 (en) Therapeutic agents
WO2004019884A3 (en) Agents and methods for enhancing bone formation
EP1582210A3 (en) Compositions and methods for treating or preventing surgical adhesions
AP9901655A0 (en) Controlled release of pharmaceuticals in the anterior chamber of the eye.
AU2002225772A1 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
MXPA03007837A (en) Compositions for delivering bisphosphonates.
MY127082A (en) Synergistic methods and compositions for treating cancer
MXPA04001334A (en) Materials and methods to promote repair of nerve tissue.
WO2003028802A3 (en) Devices for treating atrial fibrilation
BG105534A (en) 5ht1 means and method for the treatment of migraine
MXPA03010085A (en) Composition and methods for treatment of hyperplasia.
ATE375341T1 (en) THIADIAZOLYLPIPERAZINE DERIVATIVES SUITABLE FOR THE TREATMENT OR PREVENTION OF PAIN
WO2004031129A3 (en) Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
CA2378613A1 (en) Selective iglur5 receptor antagonists for the treatment of migraine
EP1420827B8 (en) 5-cnac as oral delivery agent for parathyroid hormone fragments
MXPA05007717A (en) Controlled release of highly soluble agents.
MY134562A (en) Methods and compositions to treat conditions associated with neovascularization
EP1336619A3 (en) Combination of a HVEM-LIGHT inhibitor and an immunosuppressive agent in the treatment or prevention of immune disorders
TW200503689A (en) Pharmaceutical compositions of atorvastatin
EP1441718A4 (en) Carbinols for the treatment of neuropathic dysfunction
WO2003103614A3 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
WO2000061141A3 (en) Methods and compositions for enhancing delivery of therapeutic agents to tissues
UY25824A1 (en) VITRONECTIN RECEPTOR ANTAGONIST
PL370361A1 (en) Alkyl urea retinoid agonists i
TR200200278T2 (en) Calcilitic compositions

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP